skip to main content

How to find effective natural compounds faster

Heike Brötz-Oesterhelt, CMFI's deputy spokesperson, on how to find natural compounds more quickly. A balance sheet for 2021 and current research goals of natural product research in Tübingen.

05.10.2022 CMFI News

The research group of Prof. Heike Brötz-Oesterhelt from the Interfaculty Institute of Microbiology and Infection Medicine at the Eberhard Karls University of Tübingen is looking for new antibacterial agents. A major challenge in today's natural product research is to discover and screen out already known substances at an early stage in order to have capacities for researching new active substances.

"We need information on bioactivity and mode of action as early as possible in order to focus on isolating compounds with unknown modes of action."– Heike Brötz-Oesterhelt

To this end, the researchers have developed a new bioreporter approach, which they have published in the journal Cell Chemical Biology. Bioreporters are microbial cells that have been genetically modified to produce a measurable signal in response to a specific agent in their environment - in this case, a color circle. This allows information on the mode of action of bioactive compounds to be generated as early as the primary screening stage, without the need to enrich or purify the substance. The method works along the entire purification pipeline, i.e. with culture supernatants, extracts, fractions and pure substances. Combined with high-resolution mass spectrometry, the biosensor panel is an efficient and sensitive tool for deciphering compounds. It immediately informs about the inhibited metabolic pathway, allowing the selection of targeted follow-up assays to elucidate the molecular target.

 

Balance 2021:

  •     In corallopyronin A development, completion of transfer to industrial Clinical Research Organizations and upscaling of production to large scale (15,000 liters), and pivotal tox studies in dogs. (partially implemented)
  •     Elaboration and publication of a roadmap of antibiotic development from translational academic research as part of DZIF participation in JPI-AMR.
  •     Demonstration/confirmation of in vivo proof-of-concept for supportive therapy of Pseudomonas aeruginosa infections using PqsR-inverse agonistsin combination with an aminoglycoside antibiotic.

Current projects:

  •     Demonstrate/confirm in vivo proof-of-concept for adjuvant therapy of Pseudomonas aeruginosa infections by using LecB inhibitors in combination with a standard-of-care antibiotic.
  •     Nomination of a lead structure for use against Pseudomonas aeruginosa infections.
  •     Identification and use of key transcriptional regulators to activate silent gene clusters and identify novel antibiotically active natural products.


(Text: DZIF Annual Report 2021; Translation: Leon Kokkoliadis)

More Information

New bioreporter approach increases chances of discovering unknown bioactive compounds

CMFI News, 30.03.2021

 

Bioreporters for direct mode of action-informed screening of antibiotic producer strains

Wex K W, Saur J S, Handel F, Ortlieb N, Mokeev VKulik A, Niedermeyer T H J, Mast Y, Grond S, Berscheid A, Brötz-Oesterhelt H. CellChemBio (2021), doi: 10.1016/j.chembiol.2021.02.022.

Scientific Contact

Prof. Dr. Heike Brötz-Oesterhelt

Deputy Spokesperson CMFI

University of Tübingen
Interfaculty Institute of Microbiology and Infection Medicine
Department of Microbial Bioactive Compounds

Email: heike.broetz-oesterhelt@uni-tuebingen.de

Website

 

Press Contact

Leon Kokkoliadis
Public Relations Management

Tel: +49 7071 29-74707
E-Mail: leon.kokkoliadis@uni-tuebingen.de

Related News

New bioreporter approach increases chances of discovering unknown bioactive compounds
30.03.2021 New bioreporter approach increases chances of discovering unknown bioactive compounds CMFI News
New combination of methods shortens search for bioactive compounds
08.08.2022 New combination of methods shortens search for bioactive compounds Press Release
"Hope for New Drugs Arises from the Sea"
01.08.2022 "Hope for New Drugs Arises from the Sea" In the Media

Scientific American

Only 3% of potential bacterial drug sources known
02.05.2022 Only 3% of potential bacterial drug sources known CMFI News
"Den körpereigenen Schutzschild aktivieren"
17.09.2021 "Den körpereigenen Schutzschild aktivieren" In the Media

Schwäbisches Tagblatt

55

Related Articles

Solving Problems of Today: CMFI Researchers Receive Technology Transfer Award
04.07.2024 Solving Problems of Today: CMFI Researchers Receive Technology Transfer Award CMFI News
New tool maps microbial diversity with unprecedented details
21.06.2024 New tool maps microbial diversity with unprecedented details Press Release
Clinical trial of innovative phage lysin HY-133 initiated
11.06.2024 Clinical trial of innovative phage lysin HY-133 initiated Press Release
"‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds"
04.06.2024 "‘Raspberry Mineral’ Could Be Evidence Of Microbial Life On Early Earth And Other Worlds" In the Media

Forbes

"LuCa" project is funded by Else Kröner-Fresenius Foundation
16.05.2024 "LuCa" project is funded by Else Kröner-Fresenius Foundation CMFI News
“Medizinische Studien für vulnerable Personen: Medizinethiker Prof. Urban Wiesing”
16.05.2024 “Medizinische Studien für vulnerable Personen: Medizinethiker Prof. Urban Wiesing” In the Media

BR2